National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Interventional Fluoroscopy: Reducing Radiation Risks for Patients and Staff
    Posted: 04/18/2005



Introduction






Increasing use and complexity






Determinants of radiation dose






Radiation risks






Strategies to optimize radiation exposure






Physician-patient communication before and after






Dosimetry records and follow up






Education and training






Conclusion






Reference list



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Physician-patient communication before and after interventional fluoroscopy

Operators should always ask the patient about any previous history of interventional fluoroscopy before undertaking another procedure. It is important to communicate the details of the procedure, patient dose, and immediate and potential long-term health effects to patients and their primary care providers.

Before procedure

Patients should be counseled on radiation-related risks, as appropriate, along with the other risks and benefits associated with the procedure. If patients are likely to have multiple interventional fluoroscopy procedures in a short period of time, they should be informed if there is a possibility that significant radiation exposures may accompany these procedures and may cause potential short-term and long-term radiation-related health effects.

After procedure

After a procedure, the measured or estimated radiation dose should be reviewed (Miller 2004), and appropriate steps should be taken to insure adequate patient follow-up:

  • Schedule a follow-up visit 30 days after the procedure for all patients who received a radiation skin dose of 2 Gy or more or a cumulative dose of 3 Gy or more.
  • Send the interventional fluoroscopy procedure description, operative notes, doses and information about possible short-term and long-term effects to the patient's primary care provider.
  • The patient and primary care physician should be specifically requested to notify the operator if observable skin effects occur.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov